Microfluidic Cell Culture Analog Systems for Physiological Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro cell culture methods fail to accurately mimic human and mammalian responses to chemicals due to their inability to replicate the dynamic interactions and mechanical forces present in vivo, leading to incomplete toxicity testing and drug development challenges.
Innovation Solution
Development of cell culture analog systems comprising biologically functional cells and microscale devices that mimic in vivo physiological conditions, including cardiac, hepatic, and neural components, with dynamic control of culture parameters to simulate organ systems and interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If static multi-well plate systems are used for in vitro testing, then simplicity and ease of operation are improved, but the ability to capture physiological response and predict human response deteriorates
Solution Approach 1:
The patent implements dynamic cell culture systems with continuous media flow through microfluidic channels, replacing static multi-well plates. This enables time-dependent changes in chemical concentration at tissue sites, mimicking in vivo absorption, distribution, metabolism and excretion processes, thereby improving predictive accuracy while maintaining operational simplicity through automated flow control
Solution Approach 2:
The patent divides the culture system into multiple interconnected tissue/organ compartments (e.g., liver, kidney, heart chambers) that are spatially separated but functionally connected through fluid flow. This segmentation allows different cell types to be cultured in anatomically relevant configurations, enabling metabolite exchange between compartments and improving physiological response capture
2Device complexity
If single cell or tissue type systems are used, then device complexity is reduced, but the ability to model metabolite exchange between tissue compartments deteriorates
Solution Approach 1:
The patent creates multiple discrete culture chambers representing different tissue types (hepatic, cardiac, renal, gastrointestinal) that are interconnected through microfluidic channels. Each chamber can contain specific cell types while maintaining individual control, yet the system as a whole models metabolite exchange and physiological interactions between organ systems
Solution Approach 2:
The patent designs a universal microfluidic platform that can accommodate multiple tissue types and experimental configurations within a single integrated device. The modular chamber design allows different cell types to be cultured in standardized compartments, enabling the system to model various physiological scenarios without requiring separate devices for each tissue type
3Ease of manufacture
If isolated cell cultures without mechanical forces are used, then ease of manufacture is improved, but the ability to represent functional tissues and control gene expression deteriorates
Solution Approach 1:
The patent incorporates microfluidic flow systems that generate mechanical forces (shear stress, fluid flow) on cultured cells through controlled media circulation. This hydraulic approach enables cells to experience physiological mechanical stimuli that regulate gene expression and metabolism, improving tissue functionality representation while maintaining ease of manufacture through standard microfluidic fabrication techniques
Data Source
AI summary
The present invention comprises methods, systems and compositions comprising cell culture analog systems, comprising components which optionally comprise biologically functional cells, and the components and systems function similarly to in vivo conditions.